Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Zynerba Pharmaceuticals, Inc. (ZYNE) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/09/2023 4 Rosenberger Brian (VP, Commercial & Business Dev.) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.
Txns: Granted 14,926 shares @ $0
Paid exercise price by delivering 5,145 shares @ $0.5965, valued at $3.1k
02/09/2023 4 Fickenscher James E (CFO) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.
Txns: Granted 22,547 shares @ $0
Paid exercise price by delivering 6,544 shares @ $0.5965, valued at $3.9k
02/09/2023 4 Sebree Terri B (President) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.
Txns: Granted 36,044 shares @ $0
Paid exercise price by delivering 9,973 shares @ $0.5965, valued at $5.9k
02/09/2023 4 ANIDO ARMANDO (Chairman & Chief Exec. Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.
Txns: Granted 45,406 shares @ $0
Paid exercise price by delivering 12,547 shares @ $0.5965, valued at $7.5k
02/09/2023 4 Parker Albert P (Chief Legal Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.
Txns: Granted 18,864 shares @ $0
Paid exercise price by delivering 5,463 shares @ $0.5965, valued at $3.3k
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/25/2023 4 Parker Albert P (Chief Legal Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.
Txns: Granted 170,000 shares @ $0
01/25/2023 4 Sebree Terri B (President) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.
Txns: Sold 24,661 shares @ $0.5978, valued at $14.7k
Granted 170,000 shares @ $0
01/25/2023 4 Fickenscher James E (CFO) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.
Txns: Sold 17,769 shares @ $0.5978, valued at $10.6k
Granted 170,000 shares @ $0
01/25/2023 4 Rosenberger Brian (VP, Commercial & Business Dev.) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.
Txns: Sold 12,663 shares @ $0.5978, valued at $7.6k
Granted 120,000 shares @ $0
01/25/2023 4 ANIDO ARMANDO (Chairman & Chief Exec. Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.
Txns: Sold 35,453 shares @ $0.5978, valued at $21.2k
Granted 250,000 shares @ $0
07/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/20/2022 4 Rosenberger Brian (VP, Commercial & Business Dev.) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.
Txns: Granted 14,800 shares @ $0
Sold 4,289 shares @ $1.1, valued at $4.7k
07/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy